Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether an oxytocin ad-on, or oxytocin and tibolone
ad-on can induce a response to antidepressants in patients with treatment resistant
depression.
Phase:
Phase 1
Details
Lead Sponsor:
The Alfred
Collaborator:
Monash University
Treatments:
Bone Density Conservation Agents Estrogens Oxytocin Tibolone